U.S. markets closed

Palantir Technologies Inc. (PLTR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
27.66-1.39 (-4.78%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close29.05
Open31.19
Bid28.26 x 1400
Ask28.39 x 1100
Day's Range26.12 - 33.50
52 Week Range8.90 - 33.50
Volume205,356,226
Avg. Volume60,906,290
Market Cap51.944B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Top 3rd-Quarter Buys of Steven Cohen's Firm
    GuruFocus.com

    Top 3rd-Quarter Buys of Steven Cohen's Firm

    Point72 reaffirms its focus on tech and health care

  • Palantir Adds $17 Billion in Value in Best Week Since Debut
    Bloomberg

    Palantir Adds $17 Billion in Value in Best Week Since Debut

    (Bloomberg) -- Palantir Technologies Inc. posted its best week since it went public in September, adding about $17 billion in market value as a broad rally in tech stocks helped fuel gains in the software maker.Its shares rose 52% since Monday and touched a fresh intraday record at $33.50. The stock lost some of the gains on Friday after Citron Research said in a tweet it was shorting the stock with a $20 target. The company ended the session at $27.66.Palantir representatives didn’t respond to a request for comment.“A lot of institutions have probably warmed up to the company and are viewing it as something to hold onto for the long term,” said Wayne Kaufman, chief market analyst at Phoenix Financial Services. “It’s a great software company, and it has a terrific business, a very sticky business, not just with governments but also enterprises.”Trading in Palantir options also surged this week with average daily volume of call contracts jumping about 250% in the first three days of the week when compared to the prior week. An analysis of open interest shows most of the contracts being opened and closed in the same day, indicating a heavy presence of day traders.After an initial lackluster performance following its direct-listing stock debut, gains for the Denver-based firm, which sells data-analysis tools, have accelerated after hedge funds, including Steve Cohen’s Point72 Asset Management, reported purchasing the company’s shares.“Big-data companies have become very important and historically have been excellent stocks. Also, Palantir is benefiting from the pandemic -- tracking cases and analyzing data is right in its wheelhouse,” Kaufman said.Since starting up in 2003, co-founder and chairman Peter Thiel has helped bankroll the business throughout its long period as a closely held business. Now, the stock has gained nearly 300% since its direct listing. It reported third-quarter losses in its first financial results since going public as compensation costs surged. It did, however, boost its revenue growth forecast for the year to 44%, exceeding the amount analysts expected on average.“I’d say the days of it trading below $20 are probably over,” Kaufman added.(Updates closing prices, adds comments.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Dow Jones Today, Stocks Climb Into Short Session After AstraZeneca Vaccine Bump
    Investor's Business Daily

    Dow Jones Today, Stocks Climb Into Short Session After AstraZeneca Vaccine Bump

    Palantir and Moderna were early leaders Friday, while a rebounding Intel led the Dow Jones, as stocks piled into a short trading session.